Zenith has never given a Fair Market Value, they have given a Fair Value. Two different things and that is why they say it is for financial statements only. FV's of non-trading companies are notoriously lower than FMV's. The fact that Zenith qualifies for registered accounts has never been the issue. They are a qualifying public company. The transfer price is the only issue. On August 9th, 2016, Scotia iTrade sent me a letter stating,

"We have recently been advised by the company they have completed the required filing with Canada Revenue Agency (CRA) to be considered a Public Corporation. Therefore the shares of Zenith Epigenetics are now deemed to be a Qualified Investment and no further action will be required on your part." 

Scotia iTrade had originally told me they did not qualify and that I had to move them until they received clarification by Zenith that the filings were done. The name on the shares we own was changed from Zenith Epigenetics to Zenith Capital on August 18/16 so that filing would carry to Zenith Capital as it is the corporation with just a name change. 

In 2013, shortly after the split from RVX, Zenith gave us a letter stating that the shares would be qualified investments after they made the required elections with CRA. Zenith stated that the shares met the prescribed conditions and that they had made the first required election. They also stated that they would make the second election on a timely basis. They also continued with, " the shares thereof qualified investments from the time they were issued under the plan of arrangement."

The letter from Scotia iTrade confirms that all conditions were met.